Antiviral Therapies and Drug Development

Antiviral therapies and drug development play a crucial role in combating viral infections and improving public health. With the constant threat of emerging viral pathogens and the challenges posed by viral outbreaks such as influenza, HIV/AIDS, and COVID-19, the development of effective antiviral treatments is of paramount importance. Antiviral therapies encompass a wide range of strategies, including direct-acting antivirals, immunomodulators, and combination therapies. Advances in drug development have led to the discovery of novel antiviral agents targeting specific viral enzymes, viral entry mechanisms, and viral replication processes.

 

    Related Conference of Antiviral Therapies and Drug Development

    March 17-18, 2025

    54th World Congress on Microbiology

    Berlin, Germany
    July 28-29, 2025

    17th International Virology Summit

    Paris, France
    August 25-26, 2025

    6th International Conference on Molecular Microbiology

    Singapore City, Singapore
    September 22-23, 2025

    13th World Congress and Expo on Applied Microbiology

    Dubai, UAE

    Antiviral Therapies and Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in